Skip to main content

Advertisement

SpringerLink
Log in

Nocturia Now

The Evolution of Diagnosis and Treatment

  • Female Stress Incontinence and Prolapse (R Dmochowski, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Nocturia is a highly prevalent and bothersome condition, associated with serious medical conditions, as well as increased mortality risk. Nonetheless, it remains an underreported, underdiagnosed, and undertreated condition, with many patients believing it to be a natural consequence of aging. Recent studies have improved our understanding of nocturia while introducing a growing number of therapeutic options. This paper aims to review the classification, etiology, associated morbidity and treatment of nocturia with evidence from the most recent literature published within the past year.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Weiss JP, Blaivas JG, Bliwise DL, et al. The evaluation and treatment of nocturia: a consensus statement. BJU Int. 2011;108(1):6–21. The paper represents the recommendations of a panel of experts convened at an interdisciplinary conference on nocturia; most current research, evaluation, and treatment of nocturia are summarized.

    Article  PubMed  Google Scholar 

  2. Weiss JP, Wein AJ, van Kerrebroeck P, et al. Nocturia: new directions. Neurourol Urodyn. 2011;30(5):700–3.

    Article  PubMed  Google Scholar 

  3. • Yoshimura K. Correlates for nocturia: a review of epidemiological studies. Int J Urol. 2012 Jan 13.

  4. •• Weiss JP, van Kerrebroeck PE, Klein BM, Nørgaard JP. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. Urology. 2011;78(3):631–5. This study demonstrates that nocturnal polyuria is a major causative factor of nocturia. New understandings and treatments for nocturia have evolved from this principle.

    Article  Google Scholar 

  5. Zhang X, Zhang J, Chen J, et al. Prevalence and risk factors of nocturia and nocturia-related quality of life in the Chinese population. Urol Int. 2011;86(2):173–8.

    Article  PubMed  Google Scholar 

  6. • Tikkinen KAO, Auvinen A, Johnson TM, et al. A Systemic Evaluation of Factors Associated with Nocturia – the Population-based FINNO Study. Am J Epidemiol. 2009;170(3):361–8. A large questionnaire-based trial evaluating correlates for nocturia amongst the Finnish population.

    Article  PubMed  Google Scholar 

  7. Brunner A, Riss P. Nocturia in women. Maturitas. 2011;70(1):16–21.

    Article  PubMed  Google Scholar 

  8. Markland AD, Vaughan CP, Johnson 2nd TM, et al. Prevalence of nocturia in United States men: results from the National Health and Nutrition Examination Survey. J Urol. 2011;185(3):998–1002.

    Article  PubMed  Google Scholar 

  9. Cornu J-N, et al. A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis. Eur Urol (2012)

  10. Tandeter H, Gendler S, Dreiher J, Tarasiuk A. Nocturic episodes in patients with benign prostatic enlargement may suggest the presence of obstructive sleep apnea. J Am Board Fam Med. 2011;24(2):146–51.

    Article  PubMed  Google Scholar 

  11. Liao CH, Chiang HS, Yu HJ. Serum testosterone levels significantly correlate with nocturia in men aged 40–79 years. Urology. 2011;78(3):631–5.

    Article  PubMed  Google Scholar 

  12. Kim SO, Choi HS, Kim YJ, et al. Impact of nocturia on health-related quality of life and medical outcomes study sleep score in men. Int Neurourol J. 2011;15(2):82–6.

    Article  PubMed  Google Scholar 

  13. Yoo SS, Shim BS, Lee DH, Lee HW, Yoon H. Correlation between Nocturia and Sleep: a Questionnaire Based Analysis. Korean J Urol. 2010;51(11):757–62.

    Article  PubMed  Google Scholar 

  14. Kupelian V, Fitzgerald MP, Kaplan SA, et al. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol. 2011;185(2):571–7.

    Article  PubMed  Google Scholar 

  15. van Doorn B, Kok ET, Blanker MH, Westers P, Bosch JL. Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J Urol. 2012;187(5):1727–31.

    Article  PubMed  Google Scholar 

  16. Namiki S, Takegami M, Ishidoya S, Numata I, Arai Y. Impact of nocturia on disease-specific quality of life for men with localized prostate cancer. Qual Life Res. 2011;20(10):1609–15.

    Article  PubMed  Google Scholar 

  17. Cho SY, Lee SL, Kim IS, et al. Short-term effects of systematized behavioral modification program for nocturia: a prospective study. Neurourol Urodyn. 2012;31(1):64–8.

    Article  PubMed  Google Scholar 

  18. Kojima Y, Sasaki S, Imura M, et al. Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart. Neurourol Urodyn. 2012;31(1):80–5.

    Article  PubMed  CAS  Google Scholar 

  19. Zhang K, Yu W, Jin J, et al. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study. Urology. 2011;78(3):636–40.

    Article  PubMed  Google Scholar 

  20. Yokoyama O, Yamaguchi O, Kakizaki H, et al. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. J Urol. 2011;186(1):170–4.

    Article  PubMed  CAS  Google Scholar 

  21. Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology. 2008;72(4):813–6.

    Article  PubMed  Google Scholar 

  22. Shin HI, Kim BH, Chang HS, et al. Long-term effect of loxoprofen sodium on nocturia in patients with benign prostatic hyperplasia. Korean J Urol. 2011;52(4):265–8.

    Article  PubMed  Google Scholar 

  23. Hirayama A, Torimoto K, Yamada A, et al. Relationship between nocturnal urine volume, leg edema, and urinary antidiuretic hormone in older men. Urology. 2011;77(6):1426–31.

    Article  PubMed  Google Scholar 

  24. Rezakhaniha B, Arianpour N, Siroosbakhat S. Efficacy of desmopressin in treatment of nocturia in elderly men. J Res Med Sci. 2011;16(4):516–23.

    PubMed  CAS  Google Scholar 

  25. Murphy AM, Goldman HB. Clinical trials report: low-dose oral desmopressin for nocturia. Curr Urol Rep. 2011;12(5):313–5.

    Article  PubMed  Google Scholar 

  26. Zong H, Yang C, Peng X, Zhang Y. Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials. Int Urol Nephrol. 2011 Sep 7.

  27. • Wang CJ, Lin YN, Huang SW, Chang CH. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol. 2011;185(1):219–23. BPH had been thought of as a major cause of nocturia, but new evidence suggests that nocturnal polyuria may play a larger role. This randomized placebo controlled trial demonstrated the efficacy of desmopressin on the treatment of nocturia in men with BPH.

    Article  PubMed  CAS  Google Scholar 

  28. Lee HW, Choo MS, Lee JG, et al. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity. J Korean Med Sci. 2010;25(12):1792–7.

    Article  PubMed  Google Scholar 

  29. Kang DI, Kim HM, Oh SY, et al. Short term effect and safety of antidiuretic hormone in the patients with nocturia. Int Neurourol J. 2010;14(4):227–31.

    Article  PubMed  Google Scholar 

  30. Simaioforidis V, Papatsoris AG, Chrisofos M, et al. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int J Urol. 2011;18(3):243–8.

    Article  PubMed  Google Scholar 

Download references

Disclosure

A.M. Bergman: nothing to disclose; V.J. Li: nothing to disclose; J. Weiss: consultant for Ferring, Pfizer, Allergan, and Astellas; travel/accommodation expenses covered or reimbursed by Ferring, Pfizer, Astellas.

Author information

Authors and Affiliations

  1. Department Urology, SUNY Downstate College of Medicine, 450 Clarkson Avenue, Box 79, Brooklyn, NY, 11203, USA

    J. P. Weiss

  2. SUNY Downstate College of Medicine, 450 Clarkson Avenue, Box 79, Brooklyn, NY, 11203, USA

    A. M. Bergman & V. J. Li

Authors
  1. A. M. Bergman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. J. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. P. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. P. Weiss.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergman, A.M., Li, V.J. & Weiss, J.P. Nocturia Now. Curr Bladder Dysfunct Rep 8, 13–18 (2013). https://doi.org/10.1007/s11884-012-0163-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-012-0163-6

Keywords

Search

Navigation